Dr. Rafi Aviram Appointed Executive Vice President and Director General of the Technion
Dr. Rafi Aviram, a seasoned leader with a background in academia and the military, is named Technion’s Executive VP and Director General.
News
Collaboration Framework Agreement Between the Technion and Pfizer Signed to Accelerate Scientific Breakthroughs
Technion and Pfizer have signed a collaboration framework to drive scientific breakthroughs by integrating artificial intelligence into drug development.
The Faculty of Data and Decision Sciences
Technion’s Faculty of Industrial Engineering and Management has been renamed to the Faculty of Data and Decision Sciences, aligning with its updated research and curriculum.
Dr. AI, What’s My Diagnosis?
A Technion research team has created an AI system that analyses digital biopsy scans to detect PD-L1 protein expression in breast cancer patients. This aids in tailoring immunotherapy treatments and addresses the global shortage of pathologists.
Israeli Startup to Supply Moroccan Renewable Energy Developer with Hydrogen Power
Israeli startup H2Pro, utilising technology from the Technion, has signed a strategic agreement with Moroccan renewable energy developer Gaia Energy to supply green hydrogen. This partnership aims to harness renewable resources for sustainable energy solutions.
A Once-in-500-Year Event
On 9 October, astronomers observed GRB 221009A—the most energetic gamma-ray burst ever recorded. Remarkably, Technion physicists Professors Arnon Dar and Shlomo Dado had just published a paper predicting such an event’s energy and characteristics. Their “cannonball model” links gamma-ray bursts and cosmic rays, offering new insights into these rare cosmic phenomena.
New Technology for Growing Printed Tissues for Transplantation
Technion researchers have developed CarGrow, a red algae-based microgel that prevents shrinkage in 3D-printed tissues for transplantation. Its transparent structure allows real-time monitoring of tissue growth, improving the reliability of bioprinted transplants.
Designing and Programming Living Computers
Technion and MIT scientists have engineered bacterial cells to function as living computers by integrating synthetic gene circuits that mimic neural networks. These programmable cells can perform logic operations and respond to environmental stimuli, offering promising applications in biomanufacturing and targeted therapies.
New Antibiotic “Cocktail” Can Help Combat Superbug
Technion researchers have developed an antibiotic cocktail that effectively prevents resistance in Staphylococcus aureus, a major cause of hospital-acquired infections. This innovative approach could enhance long-term treatment efficacy and combat the rise of superbugs.
Lab-Grown Muscle Sucks Up Sugar to Fight Diabetes
Technion engineers lab-grown muscle tissue that absorbs excess sugar, reducing blood glucose in diabetic mice and opening doors to new diabetes treatments.
Israeli nanotech may be able to reduce side-effects of chemotherapy
Precision dosing invention gets drugs just to affected cells and not whole body; already tested on mice with inhibitor drugs; inventors also aiming at chemo and other treatments. By NATHAN JEFFAY (Nathan Jeffay is The Times of Israel’s health and science correspondent) Scientists say that new Israeli
Is there a connection between Nobel Prize winners and the Technion?
Two of the three Nobel Prize in Physics laureates for 2022 received honorary doctoral degrees from the Technion-Israel Institute of Technology. By JUDY SIEGEL-ITZKOVICH Published: OCTOBER 8, 2022 on Jpost. Two of the three Nobel Prize in Physics laureates for 2022 received honorary doctoral degrees from the Technion-Israel Institute of Technology in